CH299535A - Process for the production of an ether of (+) - 3-oxy-N-methyl-morphinans. - Google Patents
Process for the production of an ether of (+) - 3-oxy-N-methyl-morphinans.Info
- Publication number
- CH299535A CH299535A CH299535DA CH299535A CH 299535 A CH299535 A CH 299535A CH 299535D A CH299535D A CH 299535DA CH 299535 A CH299535 A CH 299535A
- Authority
- CH
- Switzerland
- Prior art keywords
- methyl
- oxy
- ether
- production
- morphinan
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 4
- 238000000034 method Methods 0.000 title claims description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 title description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- -1 (+) -3 propyloxy-N-methyl-morphinan Chemical compound 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 239000000155 melt Substances 0.000 claims description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 2
- RMRFFCXPLWYOOY-UHFFFAOYSA-N allyl radical Chemical compound [CH2]C=C RMRFFCXPLWYOOY-UHFFFAOYSA-N 0.000 claims description 2
- 150000001875 compounds Chemical group 0.000 claims description 2
- 239000013078 crystal Substances 0.000 claims description 2
- 238000005245 sintering Methods 0.000 claims description 2
- 229940095064 tartrate Drugs 0.000 claims description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 150000002170 ethers Chemical class 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- 239000003434 antitussive agent Substances 0.000 description 2
- 229940124584 antitussives Drugs 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- 238000005684 Liebig rearrangement reaction Methods 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Substances CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 238000005937 allylation reaction Methods 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Description
Verfahren zur Herstellung eines Äthers des (+)-3-Oxy-N-methyl-morphinans. Es wurde gefunden, dass die in der Äther gruppe mehr als 1 C-Atom enthaltenden Äther des (+)-3-Oxy-N-methyl-morphinans und deren Salze wertvolle hustenlindernde Mittel sind und gegenüber den racemischen und den (-)-Verbindungen den Vorteil haben, dass sie die bei Hustenmitteln uner wünschte analgetischeWirkung nicht besitzen.
Man kann diese Äther und deren Salze erfindungsgemäss dadurch gewinnen, dass man (+)-3-Oxy-N-methyl-morphinan mit einem für die Einführung von mehr als 1 C-Atom enthaltenden, Alkyl- und Alkenyl- resten geeigneten Verätherungsmittel behan delt und, gewünschtenfalls, die irrgesättigten Äther hydriert.
Als Verätherungsmittel verwendet man vorzugsweise eine Verbindung der Formel
EMI0001.0023
wobei R1, R2 und R3 gleiche oder ver schiedene niedere Alkyl- oder Alkenyl- reste bedeuten, wobei mindestens einer von ihnen - und zwar der nach J. von Braun (Liebigs Annalen der Chemie, Band 382, [1911], Seite 5) in Reaktion tretende -mindestens zwei C-Atome enthält.
Aus den Alkenyläthern können durch Hydrierung die entsprechenden gesättigten Alkyläther hergestellt werden. Die neuen Äther geben mit anorganischen oder organi schen Säuren wasserlösliche Salze. Sie sollen als Heilmittel Verwendung finden.
Gegenstand des Patentes ist nun ein Ver fahren zur Herstellung von<B>(+)</B> -3-Propyloxy- N-methyl-morphinan, das dadurch gekenn zeichnet ist, dass man (+) -3-Oxy-N-methyl- morphinan mit einem Verätherungsmittel der Formel
EMI0001.0039
worin R1 und R2 niedere Alkyl- oder Alkenylreste und R3 einen Allylrest be deuten, behandelt, und das entstandene (+ )
-3-Allyl- oxy-N-inethyl-morphinan hydriert.
<I>Beispiel:</I> 48,2 Gewichtsteile Phenyl-allyl-dimethyl- ammoniumbromid werden in 50 Gewichtstei len iNethanol gelöst und mit 41 Gewichtsteilen methylalkoholischer Kalilauge (27,7prozentig) und 40 Raumteilen Toluol versetzt.
Das ent standene Kaliumbromid wird unter Feuchtig- keits- und Kohlensäureausschluss abfiltriert. 25,7 Gewichtsteile (+)-3-Oxy-N-methyl- morphinan werden in 800 Raumteilen Toluol gelöst und, um die Lösung wasserfrei zu machen, 250 Raumteile Toluol abdestilliert, abgekühlt und hierauf die Allylierungslauge zugefügt.
Die Lösung wird nun unter Rühren aufgeheizt, wobei zuerst Methanol, dann ein Gemisch von Methanol und Toluol, zuletzt Toluol abdestilliert. Die Reaktionslösung wird nach dem Abkühlen mit eiskalter, verdünnter Natronlauge gewaschen. Der nach dem Ab destillieren zurückbleibende Rückstand wird im Hochvakuum destilliert. Siedepunkt 139 bis 149 C/0,006 mm. Das Hydrobromid kri stallisiert aus Alkohol-Aceton und schmilzt bei 167-168 C; [a] D =+ 32,8 (c = 3 in Wasser).
20,7 Gewichtsteile (+)-3-Allyl-oxy-N-me- thy 1-morphinan-hydrobromid werden in 150 Raumteilen Methanol mit 6 Gewichtsteilen Pd-Kohle (51/o Pd-Metall) und Wasserstoff hydriert.
Nachdem die berechnete Menge Wasser stoff aufgenommen ist,. wird vom Katalysator getrennt und eingeengt. Der Rückstand wird in Wasser aufgenommen, mit Natronlauge alkalisch gestellt, die Base in Äther aufgenom- men und der Äther abdestilliert. Das (+) -3- Propyloxy-N-methyl-morphinan bildet. ein Tartrat, welches mit 2 Mol Kristallwasser unter Sintern bei 98-105 C schmilzt; [a] 20 = +32,1.6 (c = 3 in Methanol).
Process for the production of an ether of (+) - 3-oxy-N-methyl-morphinans. It has been found that the ethers of (+) - 3-oxy-N-methyl-morphinans and their salts containing more than 1 carbon atom in the ether group are valuable antitussive agents and compared to the racemic and the (-) - compounds have the advantage that they do not have the undesirable analgesic effect of cough suppressants.
These ethers and their salts can be obtained according to the invention by treating (+) - 3-oxy-N-methyl-morphinane with an etherifying agent suitable for introducing more than 1 carbon atom containing alkyl and alkenyl radicals and, if desired, hydrogenating the unsaturated ethers.
A compound of the formula is preferably used as the etherifying agent
EMI0001.0023
where R1, R2 and R3 are identical or different lower alkyl or alkenyl radicals, at least one of them - namely that of J. von Braun (Liebigs Annalen der Chemie, Volume 382, [1911], page 5) in Reaction occurring - contains at least two carbon atoms.
The corresponding saturated alkyl ethers can be prepared from the alkenyl ethers by hydrogenation. The new ethers give water-soluble salts with inorganic or organic acids. They are said to be used as remedies.
The subject of the patent is now a process for the production of <B> (+) </B> -3-propyloxy- N-methyl-morphinane, which is characterized in that (+) -3-oxy-N- methyl morphinan with an etherifying agent of the formula
EMI0001.0039
where R1 and R2 are lower alkyl or alkenyl radicals and R3 is an allyl radical, treated, and the resulting (+)
-3-Allyl-oxy-N-ynethyl-morphinan hydrogenated.
<I> Example: </I> 48.2 parts by weight of phenyl-allyl-dimethylammonium bromide are dissolved in 50 parts by weight of iNethanol and mixed with 41 parts by weight of methyl alcoholic potassium hydroxide solution (27.7 percent) and 40 parts by volume of toluene.
The resulting potassium bromide is filtered off with exclusion of moisture and carbon dioxide. 25.7 parts by weight of (+) - 3-oxy-N-methylmorphinane are dissolved in 800 parts by volume of toluene and, in order to render the solution anhydrous, 250 parts by volume of toluene are distilled off, cooled and the allylation liquor is then added.
The solution is then heated with stirring, with first methanol, then a mixture of methanol and toluene, and finally toluene being distilled off. After cooling, the reaction solution is washed with ice-cold, dilute sodium hydroxide solution. The residue remaining after distilling off is distilled in a high vacuum. Boiling point 139 to 149 C / 0.006 mm. The hydrobromide crystallizes from alcohol-acetone and melts at 167-168 C; [a] D = + 32.8 (c = 3 in water).
20.7 parts by weight of (+) - 3-allyl-oxy-N-methy 1-morphinane hydrobromide are hydrogenated in 150 parts by volume of methanol with 6 parts by weight of Pd-carbon (51 / o Pd-metal) and hydrogen.
After the calculated amount of hydrogen has been absorbed. is separated from the catalyst and concentrated. The residue is taken up in water, made alkaline with sodium hydroxide solution, the base is taken up in ether and the ether is distilled off. The (+) -3-propyloxy-N-methyl-morphinan forms. a tartrate which melts with 2 mol of crystal water with sintering at 98-105 C; [a] 20 = +32.1.6 (c = 3 in methanol).
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH299535T | 1951-10-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH299535A true CH299535A (en) | 1954-06-15 |
Family
ID=4490349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH299535D CH299535A (en) | 1951-10-18 | 1951-10-18 | Process for the production of an ether of (+) - 3-oxy-N-methyl-morphinans. |
Country Status (1)
| Country | Link |
|---|---|
| CH (1) | CH299535A (en) |
-
1951
- 1951-10-18 CH CH299535D patent/CH299535A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2351281C3 (en) | Aminophenylethanolamine derivatives, their production and use | |
| CH299535A (en) | Process for the production of an ether of (+) - 3-oxy-N-methyl-morphinans. | |
| DE919468C (en) | Process for the preparation of ethers of (+) - 3-oxy-N-methylmorphinans | |
| DE1907403A1 (en) | New asymmetrical diaryloxalamides and their use as stabilizers and UV absorbers for plastics | |
| CH299103A (en) | Process for the production of an ether of (+) - 3-oxy-N-methyl-morphinans. | |
| AT221526B (en) | Process for the preparation of new thioxanthene derivatives | |
| CH304300A (en) | Process for the production of an ether of (+) - 3-oxy-N-methyl-morphinans. | |
| DE1470264C3 (en) | Process for the preparation of 1-phenyl-1 - square brackets on thienyl- (2) square brackets to -carbinols | |
| DE882092C (en) | Process for the preparation of N-substituted polyamines | |
| CH396941A (en) | Process for the preparation of new secondary amines | |
| AT230882B (en) | Process for the production of 6-aminochryses | |
| AT221504B (en) | Process for the production of new basic phenol ethers and their salts | |
| DE895454C (en) | Process for the preparation of ª-dimethylaminoethyl benzhydryl ether | |
| AT226716B (en) | Process for the preparation of new, water-soluble compounds containing at least two epoxy groups | |
| DE1493961B2 (en) | l-Hydroxy-2-alkylamino-i-phenyläthanderivate their acid addition salts, process for their production and pharmaceutical preparations | |
| CH615422A5 (en) | ||
| AT233016B (en) | Process for the preparation of new iminodibenzyl derivatives | |
| DE653073C (en) | Process for the preparation of alkylaminoalkyl ethers of apoquinine | |
| AT229292B (en) | Process for the preparation of new basic substituted diphenylalkane derivatives and their salts | |
| AT155800B (en) | Process for the production of diamino alcohols. | |
| AT254166B (en) | Process for the preparation of new 5- (3'-sec.Aminopropyl) -5H-dibenzo [a, d] cycloheptenes or the 10,11-dihydro derivatives thereof | |
| DE1620206C (en) | N-Cyclopropylmethyl-6,14-endo-ethanotetrahydronororipavine and their salts, processes for their preparation and pharmaceutical preparations containing these compounds | |
| CH358081A (en) | Process for the preparation of thioxanthenes | |
| DE2155997B2 (en) | Process for the preparation of furan compounds | |
| DE1543995A1 (en) | Process for the preparation of 5- (3-sec. Aminoalkylidene) -10,11-dihydro-5H-dibenzo [a, d] cycloheptenes |